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A B S T R A C T
Background: This study assessed the possible protective mechanisms of protocatechuic acid (PCA) against
cadmium (Cd)-induced oxidative stress and neurotoxicity in rats.
Methods: Male wistar strain rats weighing between 150–160 g were purchased and acclimatized for two
weeks. The rats were divided into seven groups of seven each; NC group received normal saline, CAD
group received 6 mg/kg of Cd-solution, CAD + PSG group received Cd-solution and prostigmine (5 mg/kg),
CAD + PCA-10 and CAD + PCA-20 groups received Cd-solution and PCA (10 mg/kg and 20 mg/kg)
respectively, PCA-10 and PCA-20 groups received 10 mg/kg and 20 mg/kg PCA each. Animals were
administered normal saline, Cd and PCA daily by oral gavage for 21 days. After which the animals were
sacrificed, the brain excised, homogenized and centrifuged. The activities of enzymes (Na+/K+-ATPase,
cholinesterases, catalase, glutathione peroxidase, superoxide dismutase) and levels of oxidative stress
markers (lipid peroxidation and reduced glutathione) linked to neurodegeneration were subsequently
assessed.
Results: Significant (p < 0.05) alterations in the enzyme activities and levels of oxidative stress markers
were observed in CAD group when compared to the NC group. However, the activities of the enzymes
were reversed in CAD + PSG and CAD + PCA groups.
Conclusions: PCA may protect against cadmium-induced neurotoxicity by altering the activities of Na+/K+-
ATPase, acetylcholinesterase, butyrylcholinesterase and endogenous antioxidant enzymes.




Neurotoxicity occurs as a result of exposure to artificial or
natural toxic substances (neurotoxic compounds) which alters the
normal functioning of the nervous system in a way that oxidative
injury or damage is inflicted on the nervous tissues [1]. This can on
the long run disrupt or even destroy the vital cells responsible for
the transmission and processing signals in the brain (neurons) and
other regions of the nervous system leading to various neurological
disorders [2]. Neurotoxicity can develop from exposure to heavy
metals, radiation treatment, chemotherapy substances, drug* Corresponding author. Present address: Department of Microbiology and
Parasitology, Federal University of Santa Maria, Av. Roraima, 97105-900 Santa
Maria, RS, Brazil.
E-mail address: saadefegha@futa.edu.ng (S.A. Adefegha).
http://dx.doi.org/10.1016/j.biopha.2016.07.017
0753-3322/ã 2016 Elsevier Masson SAS. All rights reserved.therapies, certain foods and drug abuse as well as food additives
and pesticides [3].
Cadmium (Cd) is a heavy metal and one of the most widely
distributed toxic pollutants in the environment with a long
biological half-life as a result of its low body excretion rate [4]. In
view of this, over time, continuous vulnerability to Cd tend to lead
to its accumulation thereby causing toxic effect in a variety of
tissues [5]. The main source of exposure to cadmium is food such as
grains and vegetables. Also, Cd can be taken or inhaled through the
olfactory pathways or nasal mucosa into the central and peripheral
neurons [6] which may alter the activities of the enzymes of the
central nervous system such as cholinesterases. Cd induced
toxicity is implicated in the production of reactive oxygen species
(ROS) and exhaustion of antioxidants leading to oxidative stress in
brain cells and alterations in the structural integrity of lipids [7] as
well as neutralizing enzymes, which leads to the disturbances in
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has been a target of research over the years and several researchers
have shown that the effect of cadmium in neurological damage can
be inhibited by some synthetic drugs, but this always comes with
adverse side effects [9]. Also, some recent evidences have shown
that plant phytochemicals such as polyphenols can inhibit the
effects of cadmium neurotoxicity with little or no side effect [10].
Polyphenols are the mostly available antioxidants found in
human diets. They are categorized in different classes as
flavonoids, phenolic acids and lignans. Phenolic acids are naturally
occurring compounds found in plants which are characterized
with unique structural similarities like presence of carboxylic
group as in protocatechuic, caffeic, p-coumaric, gallic, vanillic and
ferulic acids, which exhibit antioxidant properties and contribute
to the prevention of oxidative stress [11]. Recent findings by Oboh
et al. [12] reported the anticholinesterase property of caffeic and
chlorogenic acids (phenolic acids) in the management of
Alzheimer’s disease and oxidative stress. Protocatechuic acid
(3,4-hydroxylbenzoic acid) is widely distributed in hundreds of
plants as active phytoconstituent imparting various pharmacolog-
ical potentials [13]. These effects may be attributed to its
antioxidant activities, along with other possible mechanisms,
such as interaction with several enzymes involved in the
progression of some degenerative diseases.
Epidemiological and experimental evidences have affirmed
that phenolic compounds may exert several biological effects such
as antimicrobial, antihelminthic, antibacterial, anti-inflammatory,
anti-diabetic, antioxidant and neuroprotective properties [14–17].
Although few studies have demonstrated hepatoprotective, anti-
oxidative, nephroprotective, anti-cancer and neuroprotective
potentials of PCA [18–21], however, the likely mechanisms of
action of PCA in tissue and organ protection have not been fully
addressed and investigated. Thus, this present study sought to
investigate the possible neuroprotective mechanisms on cadmi-
um-induced oxidative stress and neurotoxicity in rats’ brain in vivo
and antioxidant property of PCA as typified by its effect on
antioxidant enzymes and lipid peroxidation.
2. Materials and methods
2.1. Chemicals and reagents
Chemicals such as protocatechuic acid (PCA), cadmium,
prostigmine, acetylthiocholine iodide, butyrylthiocholine iodide,
adenosine triphosphate (ATP), ouabain, ammonium molybdate,
thiobarbituric acid (TBA), dinitrophenylhydrazine (DNPH), sodium
acetate, sodium dodecyl sulphate, phosphorus red, ascorbic acid,
magnesium chloride, phosphate buffer of different molarity,
adenosine monophosphate (AMP), sodium hydroxide, benzene,
and 5,50-dithio-bis(2-nitrobenzoic acid) were bought from Sigma-
Aldrich, Chemie GmBH (Steinheim, Germany) while acetic acid
was purchased from BDH Chemical Ltd., (Poole, England). The
water used was glass distilled and all other chemicals and reagents
used are of analytical grade.
2.2. Experimental animals and design
Forty-nine male Wistar rats of 160 g average weight were
purchased from the Central Animal House, University of Ibadan,
Ibadan, Oyo State Nigeria. The rats were acclimatized in stainless
steel cages under controlled conditions of a 12 h light/dark cycle,
28  C temperature and 50% humidity for two weeks. The rats were
allowed access to food and water ad libitum. There is average
exposure to cadmium in the homes of some developing countries
that derive their drinking water from ground, well and stream
water located near industries that release cadmium as waste.Hence, we administered 6 mg/kg body weight of cadmium chloride
orally to rats in this study to mimic average human cadmium
exposure as previously reported [22–24]. The drug (prostigmine)
and PCA used in this experiment were also administered orally.
2.3. Treatment groups
The animals were divided into seven groups of seven (7) rats
each per steel cages and were treated for 21 days as follows:
NC- Wistar rats administered normal saline (Normal control).
CAD - Wistar rats administered 6 mg/kg body weight of
cadmium only.
CAD + PSG- Wistar rats administered 6 mg/kg body weight of
cadmium and treated with 5 mg/kg of prostigmine.
CAD + PCA-10 - Wistar rats administered 6 mg/kg body weight
of cadmium and treated with 10 mg/kg body weight of PCA.
CAD + PCA-20 - Wistar rats administered 6 mg/kg body weight
cadmium and treated with 20 mg/kg body weight of PCA.
PCA-10 - Wistar rats treated with 10 mg/kg body weight of PCA
only.
PCA-20 - Wistar rats treated with 20 mg/kg body weight of PCA
only.
2.4. Preparation of tissue homogenates
Rats decapitation were carried out via cervical dislocation while
the cerebral tissue (whole brain) was rapidly dissected, weighed
and placed in phosphate buffer pH 7.4 on ice. Subsequently, the
tissue was rinsed with the phosphate buffer pH 7.4 and then
homogenized with same buffer pH 7.4 (1:5 w/v), with about 10-up
and down strokes at about 1200 rev/min in a Teflon-glass
homogenizer (Pyrex Potter-Elvehjem model 7725T-45). The
homogenate was centrifuged using microhematocrit centrifuge
(LW Scientific M24) for 10 min at 3,000g to yield a pellet that was
discarded and the supernatant was used for lipid peroxidation
assay [25] as well as source of enzyme for the enzyme assays.
2.5. Experimental protocol
2.5.1. Na+/K+ –ATPase activity assay
The method described by Fiske and Subbarow. [26] was used to
measure the activity of Na+/K+-ATPase in whole brain homogenate.
Assay mixture consisted of 100 mL of Na+, K+ –ATPase substrate
buffer (pH 7.4) (containing 120 mM Tris–HCl, 0.4 mM EDTA,
200 mM NaCl, 20 mM KCl, and 24 mM MgCl2), 50 mL of supernatant
(tissue homogenate) in the presence or absence of 50 mL of ouabain
(1 mM), in a final volume of 200 mL. The reaction was initiated by
the addition of 50 mL adenosine triphosphate (ATP). After
incubating for 30 min at 37 C, the reaction was terminated by
the addition of 50 mL of 10% (w/v) trichloroacetic acid (TCA). The
inorganic phosphate (Pi) released was quantified using a reaction
mixture that contained 250 mL of ammonium molybdate
(100 mM), 200 mL of reaction mixture from first grid, 500 mL of
distilled water and 50 mL of ascorbic acid (8%). The absorbance was
read at 620 nm using a UV/Visible spectrophotometer (Jenway
Model No. 6315).
2.5.2. Acetylcholinesterase (AChE) assay
AChE activity investigation was carried out in a reaction
mixture containing 50 mL of tissue homogenate, 50 mL of 5,
50-dithiobis-(2-nitrobenzoic) acid (DTNB), 1175 mL of 0.1 M phos-
phate-buffered solution, pH 8.0). After incubation for 20 min at
25 C, 25 mL of acetylthiocholine iodide solution was added as the
substrate. The AChE activity was determined as changes in
absorbance reading at 412 nm for 3 min at 25 C [27,28] using a
UV/Visible spectrophotometer (Jenway Model No. 6315).
Fig. 1. Effects of PCA on Na+/K+ ATPase activity in cadmium-induced neurotoxicity
in rats. Values represent mean  standard deviation (n = 7).
Keys: NC group – normal control rats, treated with normal saline; CAD group – rats
treated with 6 mg/kg body weight cadmium only; CAD + PSG group – rats treated
with 6 mg/kg body weight cadmium and prostigmine; CAD + PCA-10 group – rats
treated with 6 mg/kg body weight cadmium and 10 mg/kg body weight of
protocatechuic acid (PCA); CAD + PCA-20 group – rats treated with 6 mg/kg body
weight cadmium and 20 mg/kg body weight of protocatechuic acid (PCA); PCA-10
group; normal rats treated with 10 mg/kg body weight protocatechuic acid (PCA);
PCA-20 group- normal rats treated with 20 mg/kg body weight protocatechuic acid
(PCA).
$ - CAD group was significantly (P < 0.05) different from NC group.
*- CAD + PSG and CAD + PCA-10 groups were significantly (P < 0.05) different from
CAD group.
** - CAD + PCA-20 group was significantly (P < 0.05) different from CAD group
ð - PCA-10 group was not significantly (P > 0.05) different from NC group.
# - PCA-20 was significantly (P < 0.05) different from NC.
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The modified method of Perry et al. [28] was used for the BChE
activity investigation. This was determined in a reaction mixture
containing 50 mL of tissue homogenate, 50 mL of 5, 50-dithiobis (2-
nitrobenzoic) acid (DTNB), 1175 mL of 0.1 M phosphate-buffered
solution, pH 8.0. After incubation for 20 min at 25 C, 25 mL
butyrylthiocholine iodide solution was added as the substrate, and
BChE activity was determined as changes in absorbance reading at
412 nm for 3 min at 25 C using a UV/Visible spectrophotometer
(Jenway Model No. 6315).
2.5.4. Lipid peroxidation and thiobarbituric acid reactions
300 mL of the tissue homogenate was pipette into fresh test
tubes. Subsequently, 300 mL of 8.1% sodium dodecyl sulphate
(SDS), 500 mL of acetic acid/HCl buffer (pH 3.4) and 500 mL of 0.6%
thiobarbituric acid (TBA) were added to the test tubes. This mixture
was incubated at 100 C for 1 h and TBA reactive species (TBARS)
produced were measured at 532 nm using a UV/Visible spectro-
photometer (Jenway Model No. 6315). Malondialdehyde (MDA)
was used as standard and TBARS produced was reported as MDA
equivalent [29]. The lipid peroxidation value was calculated.
2.5.5. Determination of catalase activity
Briefly, 50 mL of the test sample was added to a reacting mixture
containing 500 mL of 59 mM H2O2 and 950 mL of 50 mM phosphate
buffer (pH 7.0). The reaction was carried out at 25 C and the
decrease in absorbance at 240 nm was monitored for 3 min at 15 s
interval. A unit of the enzyme activity is defined as the amount of
enzyme catalyzing the decomposition of 1 mmol of hydrogen
peroxide per minute at 25 C and pH 7.0 [30].
2.5.6. Determination of reduced glutathione (GSH) content
1 mL of supernatant was treated with 500 mL of Ellman’s
reagent (19.8 mg of 5,50-dithiobisnitrobenzoic acid in 100 mL of
0.1% sodium citrate) and 3.0 mL of 0.2 M phosphate buffer (pH 8.0)
[31]. The absorbance was read at 412 nm in UV/Visible spectro-
photometer (Jenway Model No. 6315).
2.5.7. Determination of glutathione peroxidase (GSH-Px) activity
Tissue homogenate was obtained from supernatant after
centrifuging 5% brain homogenate at 15000  g for 10 min followed
by 10000  g for 30 min at 4 C was used. One milliliter of reaction
mixture was prepared which contained 0.3 mL of phosphate buffer
(0.1 M, pH = 7.4). 0.2 mL of 2 mM GSH, 0.1 mL of sodium azide
(10 mM), 0.1H2O2 (1 mM) and 0.3 mL of tissue homogenate. After
incubation at 37 C for 15 min, the reaction was terminated by
addition of 0.5 mL of 5% TCA. Tubes were centrifuged at 1500  g
for 5 min and the supernatant was collected. 0.2 mL of phosphate
buffer (0.1 M, pH = 7.4) and 0.7 mL of DTNB (0.4 mg/mL) were added
to 0.1 mL of reaction supernatant. After mixing, absorbance was
recorded at 420 nm [32] using UV/Visible spectrophotometer
(Jenway Model No. 6315).
2.5.8. Determination of superoxide dismutase (SOD) activity
Briefly, 0.1 mL of the tissue homogenate was diluted in 0.9 mL of
distilled water to make 1 in 10 dilutions. An aliquot of 0.2 mL of the
diluted microsome was added to 2.5 mL of 0.05 M carbonate buffer
pH 10.2 to equilibrate in a cuvette and the reaction started by the
addition 0.3 mL of 0.3 M of adrenaline. The reference cuvette
contained 2.5 mL of carbonate buffer, 0.3 mL of substrate (adrena-
line) and 0.2 mL of distilled water. The increase in absorbance at
480 nm was monitored every 30 s for 150 s [33].
2.5.9. Histological assessment
Drury and Wallington. [34] method was used for the
histological assessment. Rats brains from different groups wereinserted in 10% neutral formalin solution, dehydrated in absolute
ethanol and embedded in paraffin. Fine sections obtained were
mounted on glass slides and counter-stained with hematoxylin
and eosin (H&E) for light microscopic analyses. Photographs were
subsequently taken.
2.6. Data analysis
Results of replicate readings were pooled and expressed as
mean  standard deviation. One-way analysis of variance (ANOVA)
was used to analyze the results and turkey test was used for the
post hoc treatment [35]. Graph Pad prism 6.0 software package for
Windows was used for the analysis.
3. Results
3.1. Na+/K+-ATPase activity
In this study, the Na+/K+ ATPase activity was significantly
(P < 0.05) reduced in CAD group when compared to the NC group
(Fig. 1). Moreover, the Na+/K+ ATPase activity was significantly
(P<0.05) elevated in CAD + PSG, CAD + PCA-10 and CAD + PCA-20
groups. In addition, there was no significant (P>0.05) difference
between the PCA-10 group and NC group
3.2. Acetylcholinesterase and butyrylcholinesterase activity
Further investigation in this study showed that there was a
significant (P < 0.05) elevation in AChE activity of rats in CAD group
when compared to the NC group (Fig. 2). However, the AChE
activity was significantly (P<0.05) reduced in CAD + PSG, CAD +
PCA-10 and CAD + PCA-20 when compared to the CAD group. In
addition, there was no significant (P>0.05) difference between
PCA-10 and PCA-20 groups when compared with NC group (Fig. 2).
Fig. 2. Effects of PCA on acetylcholinesterase (AChE) activity in cadmium-induced neurotoxicity in rats’ brain. Values represent mean  standard deviation (n = 7).
Keys: NC group – normal control rats, treated with normal saline; CAD group – rats treated with 6 mg/kg body weight cadmium only; CAD + PSG group – rats treated with
6 mg/kg body weight cadmium and prostigmine; CAD + PCA-10 group – rats treated with 6 mg/kg body weight cadmium and 10 mg/kg body weight of protocatechuic acid
(PCA); CAD + PCA-20 group – rats treated with 6 mg/kg body weight cadmium and 20 mg/kg body weight of protocatechuic acid (PCA); PCA-10 group; normal rats treated with
10 mg/kg body weight protocatechuic acid (PCA); PCA-20 group- normal rats treated with 20 mg/kg body weight protocatechuic acid (PCA).
$ - CAD group was significantly (P < 0.05) different from NC group.
*- CAD + PSG group was significantly (P < 0.05) different from CAD group.
** - CAD + PCA-10 and CAD + PCA-20 groups were very significantly (P < 0.05) different from CAD group.
ð - PCA-10 and PCA-20 groups were not significantly (P > 0.05) different from NC group.
Fig. 3. Effects of PCA on butyrylcholinesterase activity (BChE) in cadmium-induced
neurotoxicity in rats. Values represent mean  standard deviation (n = 7).
Keys: NC group – normal control rats, treated with normal saline; CAD group – rats
treated with 6 mg/kg body weight cadmium only; CAD + PSG group – rats treated
with 6 mg/kg body weight cadmium and prostigmine; CAD + PCA-10 group – rats
treated with 6 mg/kg body weight cadmium and 10 mg/kg body weight of
protocatechuic acid (PCA); CAD + PCA-20 group – rats treated with 6 mg/kg body
weight cadmium and 20 mg/kg body weight of protocatechuic acid (PCA); PCA-10
group; normal rats treated with 10 mg/kg body weight protocatechuic acid (PCA);
PCA-20 group- normal rats treated with 20 mg/kg body weight protocatechuic acid
(PCA).
$ - CAD group was significantly (P < 0.05) different from NC group.
*- CAD + PSG and CAD + PCA-10 groups were significantly (P < 0.05) different from
CAD group.
** - CAD + PCA-20 group was very significantly (P < 0.05) different from CAD group.
# - PCA-10 and PCA-20 groups were significantly (P < 0.05) different from NC group.
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elevated in CAD group (P < 0.05) when compared to the NC group.
However, rat administered cadmium and treated with prostigmine
(a synthetic drug) and doses of PCA (10  20 mg/kg) had
significantly (P < 0.05) reduced BChE activity (Fig. 3).
3.3. Lipid peroxidation and antioxidant enzymes
The effect of PCA on cadmium-induced toxicity in rat brain
investigated revealed that the MDA level was significantly
(P < 0.05) elevated in CAD group when compared to the NC group.
Moreover, there was significant (P < 0.05) reduction in MDA level
in the animal groups treated with both cadmium and either
prostigmine or 10 or 20 mg/kg of PCA (Fig. 4). In addition, the
influence of PCA on catalase activity was investigated and the
result presented in Fig. 5. A dramatic reduction in catalase enzyme
activity was observed in rats administered cadmium compared to
the normal control group. However, in cadmium induced
neurotoxicity groups that were treated with prostigmine and
either 10 or 20 mg/kg PCA showed significant elevation (P<0.05)
while catalase activity in PCA-10 and PCA-20 groups were not
significantly (P>0.05) different from NC group.
Fig. 7 shows the effect of prostigmine and PCA on glutathione
peroxidase (GSH-Px) in the presence of cadmium. The phenolic
compound increased the enzyme activity, which otherwise
decreased dramatically in CAD group. There was no significant
(P > 0.05) difference between PCA-20 and NC group.
3.4. Histological examination
Figs. 9 showed the histopathological examination of the rats’
brain sections. Normal rats showed normal mild neuroglia
architecture; no significant lesions were observed (Fig. 9, Plate
1). In CAD group, the brain showed mild congestion of the
meninges and mild lesions (Fig. 9, Plate 2). The brain of rats treated
Fig. 4. Effects of PCA on lipid peroxidation (LPO) in cadmium-induced oxidative stress in rats’ brain. Values represent mean  standard deviation (n = 7).
Keys: NC group – normal control rats, treated with normal saline; CAD group – rats treated with 6 mg/kg body weight cadmium only; CAD + PSG group – rats treated with
6 mg/kg body weight cadmium and prostigmine; CAD + PCA-10 group – rats treated with 6 mg/kg body weight cadmium and 10 mg/kg body weight of protocatechuic acid
(PCA); CAD + PCA-20 group – rats treated with 6 mg/kg body weight cadmium and 20 mg/kg body weight of protocatechuic acid (PCA); PCA-10 group; normal rats treated with
10 mg/kg body weight protocatechuic acid (PCA); PCA-20 group- normal rats treated with 20 mg/kg body weight protocatechuic acid (PCA).
$ - CAD group was significantly (P < 0.05) different from NC group.
*- CAD + PSG and CAD + PCA-10 groups were significantly (P < 0.05) different from CAD group
** - CAD + PCA-20 group was very significantly (P < 0.05) different from CAD group.
# - PCA-10 group and PCA-20 were significantly (P < 0.05) different from NC group.
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day of Cd and prostigmine respectively had no significant lesions
(Fig. 9, Plate 3). Co-administration of Cd and 10 mg/kg of
protocatechuic acid; showed no significant lesion (Fig. 9, Plate
4). Likewise, co-administration of Cd and 20 mg/kg of proto-
catechuic acid; showed no significant lesion (Fig. 9, Plate 5). As
observed in Plate 6 and 7 of Fig. 9, administration of 10 and 20 mg/
kg of PCA acid per day respectively to rats revealed there were no
lesions.Fig. 5. Effects of PCA on catalase activity in cadmium-induced oxidative stress in rats’ 
Keys: NC group – normal control rats, treated with normal saline; CAD group – rats trea
6 mg/kg body weight cadmium and prostigmine; CAD + PCA-10 group – rats treated wit
(PCA); CAD + PCA-20 group – rats treated with 6 mg/kg body weight cadmium and 20 mg/
10 mg/kg body weight protocatechuic acid (PCA); PCA-20 group- normal rats treated w
$ - CAD group was significantly (P < 0.05) different from NC group.
f - CAD + PSG group was not significantly (P > 0.05) different from CAD group.
** - CAD + PCA-10 and CAD + PCA-20 groups were very significantly (P < 0.05) different 
ð - PCA-10 and PCA-20 groups were not significantly (P < 0.05) different from N4. Discussion
Neuronal damage may be caused by the free radicals’
production by cadmium which may alter the activities of key
enzymes of the nervous system [36]. Cadmium (Cd) has also been
shown to generate free radicals in the brain and threaten both the
neurons and glial cells of the CNS [37]. Consumption of diet rich in
polyphenolic compounds is speculated to be a dietary strategy
towards the prevention, treatment and/or management of severalbrain. Values represent mean  standard deviation (n = 7).
ted with 6 mg/kg body weight cadmium only; CAD + PSG group – rats treated with
h 6 mg/kg body weight cadmium and 10 mg/kg body weight of protocatechuic acid
kg body weight of protocatechuic acid (PCA); PCA-10 group; normal rats treated with
ith 20 mg/kg body weight protocatechuic acid (PCA).
from CAD group.
C group.
Fig. 6. Effects of PCA on reduced glutathione (GSH) activity in cadmium-induced oxidative stress in rats’ brain. Values represent mean  standard deviation (n = 7).
Keys: NC group – normal control rats, treated with normal saline; CAD group – rats treated with 6 mg/kg body weight cadmium only; CAD + PSG group – rats treated with
6 mg/kg body weight cadmium and prostigmine; CAD + PCA-10 group – rats treated with 6 mg/kg body weight cadmium and 10 mg/kg body weight of protocatechuic acid
(PCA); CAD + PCA-20 group – rats treated with 6 mg/kg body weight cadmium and 20 mg/kg body weight of protocatechuic acid (PCA); PCA-10 group; normal rats treated with
10 mg/kg body weight protocatechuic acid (PCA); PCA-20 group- normal rats treated with 20 mg/kg body weight protocatechuic acid (PCA).
$ - CAD group was significantly (P < 0.05) different from NC group.
*- CAD + PSG group was not significantly (P > 0.05) different from CAD group.
** - CAD + PCA-10 and CAD + PCA-20 groups were very significantly (P < 0.05) different from CAD group.
# - PCA-10 and PCA-20 groups were significantly (P < 0.05) different from NC group.
Fig. 7. Effects of PCA on glutathione peroxidase (GSH-Px) activity in cadmium-
induced oxidative stress in rats’ brain. Values represent mean  standard deviation
(n = 7).
Keys: NC group – normal control rats, treated with normal saline; CAD group – rats
treated with 6 mg/kg body weight cadmium only; CAD + PSG group – rats treated
with 6 mg/kg body weight cadmium and prostigmine; CAD + PCA-10 group – rats
treated with 6 mg/kg body weight cadmium and 10 mg/kg body weight of
protocatechuic acid (PCA); CAD + PCA-20 group – rats treated with 6 mg/kg body
weight cadmium and 20 mg/kg body weight of protocatechuic acid (PCA); PCA-10
group; normal rats treated with 10 mg/kg body weight protocatechuic acid (PCA);
PCA-20 group- normal rats treated with 20 mg/kg body weight protocatechuic acid
(PCA).
$ - CAD group was significantly (P < 0.05) different from NC group.
*- CAD + PSG group was significantly (P < 0.05) different from CAD group.
** - CAD + PCA-10 and CAD + PCA-20 groups were very significantly (P < 0.05)
different from CAD group.
# - PCA-10 group was significantly (P < 0.05) different from NC group.
ð - PCA-20 group was not significantly (P > 0.05) different from NC group.
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most especially in edible plants such as grains, vegetables, cereals
and fruits in human diet are used in folk medicine for disease
management [10,11]. PCA was reported to possess various
pharmacological potentials such as neuroprotective effects which
is adjudged to be closely correlated with its antioxidant activities
[19–21,40]. The present study investigated the possible PCA
mechanisms of action in neuronal damage induced by cadmium
chloride.
Na+/K+-ATPase is identified as a key transmembrane enzyme of
the central nervous system vital for regulation of intracellular pH,
cell volume and calcium concentration, as well as for exchange of
solutes transported by coupled systems. Excessive reduction in
Na+/K+-ATPase activity may have been associated with neuronal
damage caused by excess ROS generated as a result of cadmium
induction. As observed in Fig. 1, the decreased activity of Na+/K+-
ATPase in CAD group when compared to NC group, may be an
indication of neuronal damage which may be linked with memory
loss and deficit in cognitive function [41]. However, treatment with
10 and 20 mg/ kg body weight of PCA increased the activity of the
enzyme in rats administered cadmium (Fig. 1). The result agrees
with earlier study by Silva et al. [42] where a traumatic brain injury
was reported, following a decrease in Na+/K+-ATPase activity in the
brain and concomitant increase in lipid and protein oxidation
levels. In another study, neuroprotective role of curcumin was
reported and linked with the elevation in the activity of Na+/K+-
ATPase in regions of rats’ brain [43]. In a similar manner, Rajagopal
et al. [44] reported the elevation of Na+/K+- ATPase activity by
phenolic-rich Ocimum sanctum leaf extract after excitotoxicity
induced by monosodium glutamate. From this study, PCA altered
neurotoxicity as substantiated by its ability to increase Na+/K+-
ATPase activity after a reduced activity as a result of cadmium
induced neurotoxicity.
Oxidative stress implicated by free radicals has been implicated
in cholinergic system impairment, resulting to various neurode-
generative conditions [45]. Inhibitions of acetylcholinesterase
(AChE) and butryrlcholinesterase (BChE) activities have beenshown to be a practical strategy to minimize the hydrolysis of
acetylcholine and therapeutic targets for Alzheimer’s disease
management [46]. The observed increase in AChE activity in CAD
Fig. 8. Effects of PCA on superoxide dismutase (SOD) activity in cadmium-induced oxidative stress in rats’ brain. Values represent mean  standard deviation (n = 7).
Keys: NC group – normal control rats, treated with normal saline; CAD group – rats treated with 6 mg/kg body weight cadmium only; CAD + PSG group – rats treated with
6 mg/kg body weight cadmium and prostigmine; CAD + PCA-10 group – rats treated with 6 mg/kg body weight cadmium and 10 mg/kg body weight of protocatechuic acid
(PCA); CAD + PCA-20 group – rats treated with 6 mg/kg body weight cadmium and 20 mg/kg body weight of protocatechuic acid (PCA); PCA-10 group; normal rats treated with
10 mg/kg body weight protocatechuic acid (PCA); PCA-20 group- normal rats treated with 20 mg/kg body weight protocatechuic acid (PCA).
$ - CAD group was significantly (P < 0.05) different from NC group.
*- CAD + PSG was significantly (P < 0.05) different from CAD group.
** - CAD + PCA-10 and CAD + PCA-20 groups were very significantly (P < 0.05) different from CAD group.
# - PCA-10 and PCA-20 groups were significantly (P < 0.05) different from NC group.
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administered. However, significant (p < 0.05) reduction was
observed in rats treated with PCA as shown in Fig. 2. This is in
accordance with the earlier findings of Szwajgier and Borowiec
[47] where phenolic acids characterized from extracts of selected
fruits and vegetables were shown to inhibit acetylcholinesterase in
vitro. Also, Yash et al. [48] showed the reduction in acetylcholin-
esterase activity by PCA and reported that it ameliorated
scopolamine induced amnesia in rats in vivo. The non-significant
(p > 0.05) difference between the normal rats treated with PCA and
the control rats may be an indication of the safety of the different
doses of PCA. The inhibition of the cholinesterases activities
elevated by cadmium suggests the neuroprotective role of PCA
upon cadmium exposure. Therefore, collective inhibition of the
activities of the cholinesterases has been described to boost brain
cholinergic function and amend memory deficit associated with
AD [46]. Aside the cholinergic function, attenuating oxidative
damage may be another therapeutic approach by the use of
antioxidative agents in neuronal management.
Lipid peroxidation is a significant common cellular process
oxidative stress conditions. It involves the formation of peroxyl
radicals that can rearrange by the process of cyclisation to form
endoperoxides [49,50]. The endoperoxides so formed can disinte-
grate to form series of secondary products like a highly reactive
malondialdehyde which can react with biological substrates like
proteins and DNA [49]. The link between lipid peroxidation and
ROS was established in the report of Shukla and Chandra [51] that
malondialdehyde is a pointer of lipid peroxidation and its
attendant oxidative stress. The elevation of MDA level in rats
administered cadmium in this study may be linked to the oxidative
stress resulting from deleterious effect of metal-induced ROS on
polyunsaturated fatty acid residues of phospholipids [52]. A slight
reduction observed in the MDA levels of the PCA treated rats when
compared with the normal control rats could be likened to the
findings of Lende et al. [53] where PCA reduced the lipid
peroxidation level in mice suggesting that PCA may exertmodulatory effect on excessive ROS generated in the brain as a
result of exposure to cadmium.
The reduction in the catalase activity observed in the brain of
rats exposed to cadmium as seen in Fig. 5, may be attributed to
metal deficiency as it is established that cadmium reduces iron
levels in tissues [54], the decrease in iron levels might result in
reduction in catalase activity as iron is identified as a major
component of catalase active site. Similarly, drastic reduction in
reduced glutathione (GSH) level in the brain of cadmium-induced
neurotoxicity group when compared with the normal control was
observed. This reduced level was restored towards normalization
in CAD + PSG, CAD + PCA-10 and CAD + PCA-20 groups while GSH
levels in PCA-10 and PCA-20 were significantly (P < 0.05) different
from the NC group (Fig. 6). Depletion of GSH level of rat brain
exposed to cadmium (Fig. 6) might be as a result of heavy metals
toxicity which occurs when high metal affinity sulfhydryl group of
cysteine moiety of glutathione forms strong mercaptide complexes
that are thermo-dynamically stable with cadmium. The decreased
GSH level in cadmium treated animals suggests a possible metal
binding to the enzyme active site or an interaction between the
active amino acids of this enzymes and accumulated free radicals
[55,56]. Also, oxidation of GSH may occur as result of interaction
with the free radicals released by metals which may in turn lead to
consumption of GSH level during metal detoxification as
previously reported by Manna et al. [56]. Similarly, a substantial
reduction (P < 0.05) in superoxide dismutase activity in CAD group
compared to the NC group. It is worth noting that the results of
catalase (Fig. 5), GPx (Fig. 6) and SOD (Fig. 8) activities showed
similar trend and this may indicate that antioxidant enzyme
activities are altered by cadmium toxication in the rats. Superoxide
dismutase, a vital defense enzyme converts oxygen to hydrogen
peroxide and thus plays a vital role in protecting against damage
induced by superoxide accumulation in physiological system [57].
From this study, we suspect that cadmium inhibits many
enzymes activity by virtue of its entry into the mitochondria
thereby inhibiting protein synthesis or binding to their thiol
Fig. 9. Histopathological examination of the brain sections from: normal control rats, treated with normal saline (Plate 1); rats treated with 6 mg/kg body weight cadmium
only (Plate 2); rats treated with 6 mg/kg body weight cadmium and prostigmine (Plate 3); rats treated with 6 mg/kg body weight cadmium and 10 mg/kg body weight
protocatechuic acid (Plate 4); rats treated with 6 mg/kg body weight cadmium and 20 mg/kg body weight protocatechuic acid (Plate 5); normal rats treated with 10 mg/kg
body weight protocatechuic acid (Plate 6); normal rats treated with 20 mg/kg body weight protocatechuic acid (Plate 7).
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[58]. We suspect that the binding of cadmium to the cysteine
moiety in reduced glutathione results in the inactivation of
glutathione peroxidase, which, eventually, stall the conversion of
hydrogen peroxide to water [59]. Thus, the observed regularization
of these antioxidant enzymes activity in this study due to PCA
treatment could be adjudged as its vital potential to reduce the
levels and proliferation of reactive oxygen species and thus
development of tissue injury.
A section of this study which examined the histology of the rats’
brain tissues revealed that the intervention of PCA ameliorated the
toxic effect of Cd in rats’ brain. This also indicate the ability of PCA
to reduce degenerative changes that could result from neuronal
disorders. Wolfe and Molinoff [60] suggested brain degenerative
changes that could lead to Alzheimer's disease in people exposed
to Cd. Similarly, Sidman and Leviton [61] concluded that Cd might
induce untimely aging process. Findings from this study is in
agreement with the one recorded by Dzobo and Naik [62] who
observed a lowering effect of selenium on cadmium induced
elevated esterase activity and oxidative stress in rat organs. This
confirms the neuroprotective potential of PCA and safety in the
dose administered in this study which is within the obtainable
quantity from plant foods rich in this phenolic compound. The
possible mechanism of action of PCA against cadmium inducedneurotoxicity may be involved in the regulation of the activities of
Na+/K+-ATPase and cholinesterases with attenuation of antioxidant
status relevant to neurological diseases.
5. Conclusion
We conclude from this study that cadmium may induce
neurotoxicity in rats through the free radical mediated oxidative
stress and activation/inactivation of key enzymes. However, part of
the possible mechanism of neuroprotection of PCA may involve:
reduction in lipid peroxidation level and regulation of brain
antioxidant enzyme activities as well as the regulation of
cholinergic and Na+/K+- ATPase activities.
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